CALCULATE YOUR SIP RETURNS

Balaxi Pharmaceuticals Ltd Share Price Live

36.75

-0.96(2.55%)

Live Balaxi Pharmaceuticals Share Price Chart

Balaxi Pharmaceuticals Performance

Days Range

Previous Close₹37.71
Open₹38.09
Volume86,409
Day's Range₹36.21 - ₹38.09
52W Range₹35.67 - ₹85.58
Market Cap₹208.19 Cr

Balaxi Pharmaceuticals Fundamentals

ROCE(TTM)7.48
P/E Ratio (TTM)14.34
P/B Ratio0.87
Industry P/E33.34
Debt to Equity0.24
ROE6.09
EPS (TTM)2.63
Dividend Yield0
Book Value43.12
Face Value2
ROCE(TTM)7.48
P/E Ratio (TTM)14.34
P/B Ratio0.87
Industry P/E33.34
Debt to Equity0.24
ROE6.09
EPS (TTM)2.63
Dividend Yield0
Book Value43.12
Face Value2

Balaxi Pharmaceuticals Financials

Dec 2024Mar 2025Jun 2025Sep 2025
Net Sales73.2976.2770.7456.18
Expenses69.7864.1767.0655.49
Profit before tax6.079.660.901.38
Operating Profit5.368.640.290.21
Net Profit5.368.640.290.21
ESP in Rs0.971.560.050.04

Balaxi Pharmaceuticals Shareholding Pattern

Held bySep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters65.99%65.99%65.99%65.99%65.99%
Flls16.48%16.48%16.02%8.87%3.5%
Dlls0.02%0.02%0.02%0.02%0.02%
Public17.5%17.5%17.96%25.12%30.49%

About Balaxi Pharmaceuticals

Balaxi Ventures Limited was formerly incorporated in the name of 'The Anandam Rubber Company Limited' on September 28, 1942. The Company changed its name from 'The Anandam Rubber Company Limited' to 'Balaxi Ventures Limited' on August 08, 2017. The Company incorporated with a basic objective of running rubber and tea plantations and owns several plantations across South India. In year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading. The company previously was a investment company, but the company during the financial year 2018-19 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.e. Mr. Nirej V. Paul, Mr. V. M. Paulose, Dr. Leelamma T. J and Mrs. Jaya Paul) to acquire 1,670,036 Equity Shares representing 54.94% of the paid up share capital of the Company along with the control over the Company, pursuant to which BOPL made an Open Offer under Regulation 3(1) and Regulation 4 of SEBI (SAST) Regulations, 2011. Control and management of the Company was acquired by BOPL on May 04, 2017 and it became the new promoter of Company and their representatives i.e. Mr. Ashish Maheshwari and Mrs. Minoshi Maheshwari became the new Directors of the Company. Simultaneously, erstwhile promoters stepped down as promoters from Company on same day and Mr. Nirej V. Paul and Dr. Leelamma TJ resigned as Managing Director and as Chairperson from the Company, respectively. Under the above said Open Offer, BOPL acquired 3,30,000 equity shares representing 10.86% equity share capital of the Company. On completion of the Open Offer BOPL became the holding and Promoter Company with an aggregate shareholding of 2000036 Equity Shares (ie 65.79%). The main objects of the company were amended to include activities of International wholesale trading in pharmaceutical, food products and builders' hardware on August 08, 2018. The Company commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG products from Financial Year 2018-19. Further, in February 2019, it kickstarted Food Products business by launching a range of biscuits under the brand YAP'. The Company expanded its presence by establishing a central distribution warehouse in Guatemala, marking its entry into the third geography. This expansion helped in strengthening the distribution network and a wider customer base in 2019. In FY 2023, Company started operations in two Latin American Countries, i.e., Honduras and El Salvador and also started operations in the Central African Republic.

Parent Organisation
Indian Private
Managing Director
None
Founded
1942
NSE Symbol
BALAXI

Balaxi Pharmaceuticals Share Price History

Balaxi Pharmaceuticals Share Price History

ParticularsDetails
5-Year % change in Balaxi Pharmaceuticals share price277.21%
5-Year Highest in Balaxi Pharmaceuticals share price₹ 216.04
5-Year Lowest in Balaxi Pharmaceuticals share price₹ 13.01
1-Year % change in Balaxi Pharmaceuticals share price-55.78%
1-Year Highest in Balaxi Pharmaceuticals share price₹ 151.45
1-Year Lowest in Balaxi Pharmaceuticals share price₹ 50.42

Top Mutual Funds Invested in Balaxi Pharmaceuticals Share

Top Mutual Funds Invested in Balaxi Pharmaceuticals Share

FUND NAMEAUM(%)

Peer Comparison

Peer Comparison

StocksLTP (₹)Market Cap (cr)52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd1,831.1
20.80 (1.15%)
₹4,34,159.661,548.0 - 1,910.0View Stocks
Divis Laboratories Ltd6,471.0
-19.50 (-0.30%)
₹1,72,287.784,955.0 - 7,071.5View Stocks
Torrent Pharmaceuticals Ltd3,722.0
-8.40 (-0.23%)
₹1,26,434.152,886.45 - 3,882.2View Stocks
Cipla Ltd1,530.9
5.70 (0.37%)
₹1,23,148.761,335.0 - 1,673.0View Stocks
Dr Reddys Laboratories Ltd1,257.1
7.80 (0.62%)
₹1,04,369.381,020.0 - 1,405.9View Stocks
Lupin Ltd2,085.1
13.70 (0.66%)
₹94,659.391,795.2 - 2,402.9View Stocks

Balaxi Pharmaceuticals Ltd FAQs

Balaxi Pharmaceuticals Ltd (BALAXI) share price as of November 28, 2025, on NSE is Rs 36.75 (NSE) and Rs 36.75 (BSE) on BSE.
Yes, You can buy Balaxi Pharmaceuticals Ltd (BALAXI) shares by opening a Demat account with Angel One.
Balaxi Pharmaceuticals Ltd (BALAXI) share can be bought through the following modes:
1. Direct investment: You can buy Balaxi Pharmaceuticals Ltd (BALAXI) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Balaxi Pharmaceuticals Ltd (BALAXI) shares.
Open Free Demat Account!
Join our 3 Cr+ happy customers